Physician profile
Daniel D Bohl
NPI 1336521582
$16,013.01
in general payments reported to CMS, 2019-2025
13 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $893 · 2020: $10K · 2021: $813 · 2022: $563 · 2023: $1,564 · 2024: $941 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,360 · Education: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,360.43 |
| Education | $165.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2020 | |
| Stryker Corporation | $4,063.91 | 2019-2025 | Infinity, Inbone, Prostep Mica |
| Wright Medical Technology, INC. | $492.20 | 2019-2020 | |
| Lightbody Medical Technologies INC | $404.97 | 2024-2025 | |
| Medwest Associates | $356.78 | 2023 | |
| Fusion Orthopedics USA, LLC | $343.34 | 2023 | |
| Paragon 28, INC. | $137.79 | 2024 | Portfolio |
| Zimmer Biomet Holdings, INC. | $79.50 | 2019-2020 | |
| Acumed LLC | $40.53 | 2025 | Acumed, Innate Implant |
| Pacira Pharmaceuticals Incorporated | $36.52 | 2025 | Exparel |
| Davol INC. | $20.72 | 2025 | Arista |
| Orthofix Medical, INC. | $18.63 | 2020 | |
| Smith+Nephew, INC. | $18.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.